• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥漫性尿路上皮癌患者转移模式与原发性肿瘤特征及治疗的关系

Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma.

作者信息

Sengeløv L, Kamby C, von der Maase H

机构信息

Department of Oncology, Herlev University Hospital, Copenhagen.

出版信息

J Urol. 1996 Jan;155(1):111-4.

PMID:7490804
Abstract

PURPOSE

The anatomical pattern of recurrence and metastases in patients with urothelial cancer are described, and the relationship between treatment and features of the primary invasive tumor and the subsequent pattern of metastases is analyzed.

MATERIALS AND METHODS

Between 1976 and 1991, 240 patients with recurrent or metastatic urothelial cancer were admitted to our department.

RESULTS

The majority of the patients had recurrence within 2 years after initial diagnosis. Local recurrences and lung metastases were diagnosed significantly earlier than other metastases. Multiple sites were involved in more than half of the patients. The most common sites of recurrence were local in the bladder in 65% of the cases and bone in 35%, followed by lymph nodes in 26% and lung in 20%. The pattern of metastases was similar in patients with different histological findings, grade and location of the primary tumor. Patients younger than 60 years and those with cancer of the renal pelvis more often had distant metastases compared to older patients with bladder cancer. Local recurrences were less frequent in patients who had undergone cystectomy compared to those treated with radiotherapy only. Moreover, patients with local recurrences were likely to have metastases elsewhere.

CONCLUSIONS

Bone was the most frequent site of metastases outside the pelvis and all patients suspected to have recurrence should be examined for bone metastases. The results indicate that the pattern of recurrence and metastases are not dependent on the features of the primary tumor.

摘要

目的

描述尿路上皮癌患者复发和转移的解剖学模式,并分析治疗与原发性浸润性肿瘤特征及后续转移模式之间的关系。

材料与方法

1976年至1991年间,240例复发或转移性尿路上皮癌患者入住我科。

结果

大多数患者在初次诊断后2年内复发。局部复发和肺转移的诊断明显早于其他转移。超过半数患者出现多个部位受累。最常见的复发部位是膀胱局部,占65%,其次是骨转移,占35%,然后是淋巴结转移,占26%,肺转移占20%。不同组织学表现、原发肿瘤分级和部位的患者转移模式相似。与老年膀胱癌患者相比,60岁以下患者和肾盂癌患者更常发生远处转移。与仅接受放疗的患者相比,接受膀胱切除术的患者局部复发较少。此外,发生局部复发的患者可能在其他部位发生转移。

结论

骨是盆腔外最常见的转移部位,所有疑似复发的患者均应检查是否有骨转移。结果表明,复发和转移模式不依赖于原发性肿瘤的特征。

相似文献

1
Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma.弥漫性尿路上皮癌患者转移模式与原发性肿瘤特征及治疗的关系
J Urol. 1996 Jan;155(1):111-4.
2
The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years.对Ta期和T1期膀胱移行细胞癌患者进行至少20年的随访,观察其多次复发、进展与预后之间的关系。
J Urol. 1995 Jun;153(6):1823-6; discussion 1826-7.
3
Assessment of patients with metastatic transitional cell carcinoma of the urinary tract.转移性泌尿道移行细胞癌患者的评估
J Urol. 1999 Aug;162(2):343-6.
4
Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.根治性膀胱切除术和扩大盆腔淋巴结清扫术:仅接受手术治疗的髂总血管分叉以上淋巴结转移患者的生存率。
J Urol. 2007 Oct;178(4 Pt 1):1218-23; discussion 1223-4. doi: 10.1016/j.juro.2007.05.160. Epub 2007 Aug 14.
5
[Recurrent urothelial cancer after resection of ureteral carcinoma].输尿管癌切除术后复发性尿路上皮癌
Zhonghua Zhong Liu Za Zhi. 1998 Nov;20(6):465-7.
6
Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.膀胱移行细胞癌根治性膀胱切除术后上尿路尿路上皮复发:1069例患者10年随访分析
J Urol. 2007 Jun;177(6):2088-94. doi: 10.1016/j.juro.2007.01.133.
7
Clonal origin of lymph node metastases in bladder carcinoma.膀胱癌淋巴结转移的克隆起源
Cancer. 2005 Nov 1;104(9):1901-10. doi: 10.1002/cncr.21466.
8
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.膀胱移行细胞癌根治性膀胱切除术的疗效:来自膀胱癌研究联盟的当代系列研究
J Urol. 2006 Dec;176(6 Pt 1):2414-22; discussion 2422. doi: 10.1016/j.juro.2006.08.004.
9
Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.膀胱切除术后淋巴结阳性尿路上皮癌的临床结局及复发预测因素
J Urol. 2009 Nov;182(5):2182-7. doi: 10.1016/j.juro.2009.07.017. Epub 2009 Sep 15.
10
Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.仅出现区域上肿瘤阳性淋巴结的转移性膀胱癌患者接受综合治疗后的长期生存情况。
Eur J Surg Oncol. 2009 Apr;35(4):352-5. doi: 10.1016/j.ejso.2008.07.001. Epub 2008 Aug 22.

引用本文的文献

1
Patients with Metastatic or Locally Advanced Bladder Cancer Not Undergoing Systemic Oncological Treatment-Characteristics and Long-Term Outcome in a Single-Center Danish Cohort.未接受全身肿瘤治疗的转移性或局部晚期膀胱癌患者——丹麦单中心队列的特征及长期结局
Cancers (Basel). 2025 Mar 25;17(7):1105. doi: 10.3390/cancers17071105.
2
Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study.骨靶向药物,而非放射治疗,可改善接受派姆单抗治疗的晚期尿路上皮癌骨转移患者的生存:来自 ARON-2 研究的结果。
Clin Exp Med. 2023 Dec;23(8):5413-5422. doi: 10.1007/s10238-023-01235-6. Epub 2023 Nov 2.
3
Pedal acrometastasis secondary to urothelial carcinoma masquerading as Charcot arthropathy in a patient with diabetes.
糖尿病患者因尿路上皮癌而致的转移性踩骨骨瘤,伪装为夏科氏关节病。
BMJ Case Rep. 2023 Sep 20;16(9):e254468. doi: 10.1136/bcr-2022-254468.
4
Checkpoint Inhibitors in Bone Metastatic Disease in Solid Tumors.实体瘤骨转移疾病中的检查点抑制剂。
Curr Osteoporos Rep. 2023 Aug;21(4):323-329. doi: 10.1007/s11914-023-00798-3. Epub 2023 Jun 9.
5
A rare occurrence of a metastatic urothelial carcinoma to the thoracic vertebra: A case report.罕见的胸椎转移性尿路上皮癌病例报告
Ann Med Surg (Lond). 2022 Jan 25;74:103297. doi: 10.1016/j.amsu.2022.103297. eCollection 2022 Feb.
6
Bone metastases from urothelial carcinoma. The dark side of the moon.尿路上皮癌的骨转移。月球的阴暗面。
J Bone Oncol. 2021 Nov 28;31:100405. doi: 10.1016/j.jbo.2021.100405. eCollection 2021 Dec.
7
Racial differences in the distribution of bladder cancer metastases: a population-based analysis.膀胱癌转移分布的种族差异:一项基于人群的分析。
Cent European J Urol. 2020;73(4):407-415. doi: 10.5173/ceju.2020.0269. Epub 2020 Oct 31.
8
Metastatic non-muscle invasive bladder can-cer with cervical lymph node metastasis.转移性非肌肉浸润性膀胱癌伴颈部淋巴结转移。
Int Braz J Urol. 2019 Nov-Dec;45(6):1270-1274. doi: 10.1590/S1677-5538.IBJU.2018.0421.
9
Bone Metastases as the Only Metastatic Site in Patients With Urothelial Carcinoma: Focus on a Special Patient Population.骨转移为膀胱癌患者唯一转移部位:聚焦特殊患者人群。
Clin Genitourin Cancer. 2018 Apr;16(2):e483-e490. doi: 10.1016/j.clgc.2017.10.012. Epub 2017 Nov 1.
10
Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis.尿路上皮癌骨转移患者的骨相关事件与预后
Int J Clin Oncol. 2017 Jun;22(3):548-553. doi: 10.1007/s10147-016-1075-9. Epub 2017 Jan 2.